A carregar...
Strategies and Endpoints of Antifibrotic Drug Trials
There is an urgent need to develop antifibrotic therapies for chronic liver disease, and to clarify which endpoints in antifibrotic trials will be acceptable to regulatory agencies. AASLD sponsored an endpoints conference to help accelerate the efficient testing of antifibrotic agents and to develop...
Na minha lista:
| Publicado no: | Hepatology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515973/ https://ncbi.nlm.nih.gov/pubmed/25626988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27720 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|